Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In sheep, inflammation not only functions in cervical dilation at parturition, but also plays an important part in the non-pregnant ewe cervix, as demonstrated by the high level of expression of interleukin (IL)-8 at oestrus. Ewes artificially induced to ovulate have significantly lower levels of
IL-8
gene expression at oestrus compared with natural oestrus, indicating an inhibition of inflammation and function, offering an explanation for the low rates of conception in vaginally inseminated synchronised ewes. To identify potential pro-inflammatory agents to combat the anti-inflammatory effects of hormonal synchronisation of oestrus, we have investigated the role of proteinase-activated receptor (PAR)-1 and
PAR-2
. To localise and measure the level of expression of these receptors, ovine-specific probes were derived for PAR-1 and
PAR-2
and used for quantitative in situ hybridisation in the ovine cervix. Both PAR-1 and
PAR-2
were expressed in the luminal epithelium of the cervix throughout the oestrous cycle, with expression being highest at oestrus. The gene expression of
PAR-2
at oestrus was approximately 30% higher than that of PAR-1. Artificial synchronisation of oestrus by either an intravaginal progesterone sponge or prostaglandin F2+/- injections did not inhibit PAR-1 or
PAR-2
expression at oestrus; rather, in the case of
PAR-2
, progesterone synchronisation increased it. Both synchronising procedures increased the expression of PAR-1 and
PAR-2
during the luteal phase of the cycle. Therefore, agonists of PAR-1 and
PAR-2
may be potentially useful pro-inflammatory agents countering the inhibition of inflammation by hormonal synchronisation.
...
PMID:Proteinase-activated receptors in ovine cervical function. 1636 22
Endothelial cells react to factor Xa and thrombin by proinflammatory responses. It is unclear how these cells respond under physiological conditions, where the serine proteases factor VIIa, factor Xa and thrombin are all simultaneously generated, as in tissue factor-driven blood coagulation. We studied the Ca(2+) signaling and downstream release of interleukins (ILs), induced by these proteases in monolayers of human umbilical vein endothelial cells. In single cells, factor Xa, but not factor VIIa, complexed with tissue factor, evoked a greatly delayed, oscillatory Ca(2+) response, which relied on its catalytic activity and resembled that of SLIGRL, a peptide specifically activating the
protease-activated receptor 2
(
PAR2
). Thrombin even at low concentrations evoked a rapid, mostly non-oscillating Ca(2+) response through activation of PAR1, which reinforced the factor Xa response. The additive Ca(2+) signals persisted, when factor X and prothrombin were activated in situ, or in the presence of plasma that was triggered to coagulate with tissue factor. Further, thrombin reinforced the factor Xa-induced production of
IL-8
, but not of IL-6. Both interleukins were produced in the presence of coagulating plasma. In conclusion, under coagulant conditions, factor Xa and thrombin appear to contribute in different and additive ways to the Ca(2+)-mobilizing and proinflammatory reactions of endothelial cells. These data provide first evidence that these serine proteases trigger distinct signaling modules in endothelium that is activated by plasma coagulation.
...
PMID:Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation. 1676 66
Tryptic enzymes such as tryptase, trypsin and thrombin are reportedly able to alter neutrophil behavior. However, little is known of the influence of these proteinases on lactoferrin or
IL-8
release from neutrophils. In the present study, we investigated the effects of tryptase, trypsin, thrombin and elastase, and agonist peptides of PAR-1 SFLLR-NH(2) and
PAR-2
SLIGKV-NH(2) and tc-LIGRLO-NH(2) on lactoferrin and
IL-8
release from highly purified human neutrophils. Flow cytometry shows CD16(+) neutrophils express PAR-1 and
PAR-2
, but not PAR-3 and PAR-4 proteins. RT-PCR analysis reveals that neutrophils express only
PAR-2
genes. Tryptase and trypsin, but not thrombin and elastase, induced significant lactoferrin and
IL-8
secretion from neutrophils. SLIGKV-NH(2) and tc-LIGRLO-NH(2), but not SFLLR-NH(2), also stimulated lactoferrin and
IL-8
secretion from neutrophils. In conclusion, only a proportion of neutrophils express PAR-1 and/or
PAR-2
. Tryptase and trypsin-induced lactoferrin and
IL-8
secretion from neutrophils most likely occur through activation of
PAR-2
.
...
PMID:Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2. 1682 Mar 7
Allergenic serine proteases are important in the pathogenesis of asthma. One of these, Pen c 13, is the immunodominant allergen produced by Penicillium citrinum. Many serine proteases induce cytokine expression, but whether Pen c 13 does so in human respiratory epithelial cells is not known. In this study, we investigated whether Pen c 13 caused
IL-8
release and activated protease-activated receptors (PARs) in airway epithelial cells. In airway-derived A549 cells and normal human airway epithelial cells, Pen c 13 induced
IL-8
release in a dose-dependent manner. Pen c 13 also increased
IL-8
release in a time-dependent manner in A549 cells. Pen c 13 cleaved PAR-1 and
PAR-2
at their activation sites. Treatment with Pen c 13 induced intracellular Ca(2+) mobilization and desensitized the cells to the action of other proteases and PAR-1 and
PAR-2
agonists. Moreover, Pen c 13-mediated
IL-8
release was significantly decreased in Ca(2+)-free medium and was abolished by the protease inhibitors, PMSF and 4-(2-aminoethyl) benzenesulfonyl fluoride. Blocking Abs against the cleavage sites of PAR-1 and
PAR-2
, but not of PAR-4, inhibited Pen c 13-induced
IL-8
production, as did inhibition of phospholipase C. Pen c 13 induced
IL-8
expression via activation of ERK 1/2, and not of p38 and JNK. In addition, treatment of A549 cells or normal human airway epithelial cells with Pen c 13 increased phosphorylation of ERK 1/2 by a Ca(2+)-dependent pathway. These finding show that Pen c 13 induces
IL-8
release in airway epithelial cells and that this is dependent on PAR-1 and
PAR-2
activation and intracellular calcium.
...
PMID:Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2. 1740 7
Protease-activated receptors (PARs) are involved in the contribution of airway epithelial cells to the development of inflammation by release of pro- and anti-inflammatory mediators. Here, we evaluated in epithelial cells the influence of LPS and continuous PAR activation on PAR expression level and the release of the proinflammatory chemokine
IL-8
. We studied primary human small airway epithelial cells and two airway epithelial cell lines, A549 and HBE cells. LPS specifically upregulated expression of
PAR-2
but not of PAR-1. Exposure of epithelial cells to PAR-1 or
PAR-2
agonists increased the PAR-1 expression level. The
PAR-2
agonist exhibited higher potency than PAR-1 activators. However, the combined exposure of epithelial cells to LPS and PAR agonists abrogated the PAR-1 upregulation. The
PAR-2
expression level was also upregulated after exposure to PAR-1 or
PAR-2
agonists. This elevation was higher than the effect of PAR agonists on the PAR-1 level. In contrast to the PAR-1 level, the
PAR-2
level remained elevated under concomitant stimulation with LPS and
PAR-2
agonist. Furthermore, activation of
PAR-2
, but not of PAR-1, caused production of
IL-8
from the epithelial cells. Interestingly, both in the epithelial cell line and in primary epithelial cells, there was a potentiation of the stimulation of the
IL-8
synthesis and release by
PAR-2
agonist together with LPS. In summary, these results underline the important role of
PAR-2
in human lung epithelial cells. Moreover, our study shows an intricate interplay between LPS and PAR agonists in affecting PAR regulation and
IL-8
production.
...
PMID:PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. 1776 88
The mechanism underlying protease-activated receptor (PAR)-activation and subsequent interleukin (IL)-8 production in airway epithelial cells is not yet understood. In this study we investigated the role of mitogen-activated protein kinases (MAPKs) in A549 airway epithelial cells. We studied the consequence of activation of PARs with simultaneous exposure to LPS. Thrombin,
PAR-2
-activating peptide and LPS, were tested alone and in combination. They induced significant synthesis of
IL-8
. However, only activation of PAR triggered phosphorylation of ERK1/2 and JNK. The application of the inhibitors of these two MAPKs resulted in reduction of
IL-8
production. Thus, activation of PARs but not stimulation with LPS leads to ERK1/2 and JNK-mediated production of
IL-8
.
...
PMID:Protease-activated receptor (PAR)-induced interleukin-8 production in airway epithelial cells requires activation of MAP kinases p44/42 and JNK. 1808 57
A member of a new subfamily of G protein-coupled receptors,
protease-activated receptor 2
(
PAR2
), is highly expressed on endothelial cells and plays an important role in inflammation. The purpose of this study was to determine the molecular mechanism used by
PAR2
to induce
IL-8
production and thereby mediate cell adhesion. We observed that
PAR2
-activating peptide (PAR2-AP) significantly increase peripheral blood mononuclear cells adhere to endothelial cells. Both
PAR2
-AP and the endogenous
PAR2
activator trypsin caused concentration- and time-dependent increase in endothelial
IL-8
production, and this effect was concentration dependently and selectively attenuated by the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580. Western blotting analysis showed that
PAR2
-AP induced phosphorylation of p38 MAPK and its upstream protein kinase MAPK kinase 3/6 (MKK3/6) in a time-dependent manner. Using reverse-transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay,
PAR2
-AP was found to cause an increase in
IL-8
mRNA expression and its transcription factor activating transcription factor 2, respectively,. As expected, these signals were suppressed by SB203580 in a concentration-dependent manner. Furthermore, introduction of dominant-negative vectors targeting p38 MAPK, MKK3, and MKK6 abolished
PAR2
-AP-mediated
IL-8
production and cell adhesion function. In conclusion,
PAR2
via p38 MAPK signaling regulates
IL-8
production and thereby mediates cell adhesion.
...
PMID:The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion. 1827 46
Cysteine proteinases from Porphyromonas gingivalis, or gingipains, are considered to be key virulence factors of the bacterium in relation to periodontal diseases. Incubation of human oral epithelial cells with lysine-specific gingipain (Kgp) and high-molecular-mass arginine-specific gingipain (HRgpA) resulted in a decrease in the production of interleukin (IL)-8, but not in the production of other pro-inflammatory cytokines. In contrast, arginine-specific gingipain 2 (RgpB) increased
IL-8
production. RNA interference assays demonstrated that Kgp- and HRgpA-mediated downregulation and RgpB-mediated upregulation occurred through protease-activated receptor (PAR)-1 and
PAR-2
signalling. Although the RgpB-mediated upregulation of
IL-8
production occurred through nuclear factor-kappa B (NF-kappaB), the Kgp- and HRgpA-mediated downregulation was not negated in NF-kappaB-silenced cells. Both the haemagglutinin and the enzymic domains are required for Kgp and HRgpA to downregulate the production of
IL-8
in human oral epithelial cells, and the two domains are thought to co-exist. These results suggest that gingipains preferentially suppress
IL-8
, resulting in attenuation of the cellular recognition of bacteria, and as a consequence, sustain chronic inflammation.
...
PMID:Dual regulation of interleukin-8 production in human oral epithelial cells upon stimulation with gingipains from Porphyromonas gingivalis. 1834 72
In this study, we focus on salmon trypsin as an activator of inflammatory responses in airway cells in vitro. The rationale behind the investigation is that salmon industry workers are exposed to aerosols containing enzymes, which are generated during industrial processing of the fish. Knowing that serine proteases such as trypsin are highly active mediators with diverse biological activities, the stimulation of nuclear factor-kappa B (NF-kappaB) and interleukin (IL)-8 and the role of protease-activated receptors (PAR) in inflammatory signal mediation were investigated. Protease-activated receptors are considered important under pathological situations in the human airways, and a thorough understanding of PAR-induced cellular events and their consequences in airway inflammation is necessary. Human airway epithelial cells (A549) were exposed to trypsin isolated from fish (Salmo salar), and we observed that purified salmon trypsin could generate secretion of
IL-8
in a concentration-dependent manner. Furthermore, we demonstrate that
PAR-2
activation by salmon trypsin is coupled to an induction of NF-kappaB-mediated transcription using a
PAR-2
transfected HeLa cell model. Finally, we show that the release of
IL-8
from A549 following stimulation with purified salmon trypsin is mediated through activation of
PAR-2
using specific small interfering RNAs (siRNAs). The results presented suggest that salmon trypsin, via activation of
PAR-2
, might influence inflammation processes in the airways if inhaled in sufficient amounts.
...
PMID:Salmon trypsin stimulates the expression of interleukin-8 via protease-activated receptor-2. 1840 Feb 42
There is accumulating evidence that activation of sphingosine kinase 1 (SPHK1) is an important element in intracellular signalling cascades initiated by stimulation of multiple receptors, including certain growth factor, cytokine, and also G-protein coupled receptors. We here report that stimulation of the lung epithelial cell line A549 by thrombin leads to transient increase of SPHK1 activity and elevation of intracellular sphingosine-1-phosphate (S1P); abrogation of this stimulation by SPHK1-specific siRNA, pharmacological inhibition, or expression of a dominant-negative SPHK1 mutant blocks the response to thrombin, as measured by secretion of MCP-1, IL-6,
IL-8
, and PGE(2). Using selective stimulation of proteinase-activated receptors (PARs) a specific involvement of SPHK1 in the PAR-1 induced responses in A549 cell, including activation of NFkappaB, was evident, while
PAR-2
and PAR-4 responses were independent of SPHK1. Moreover, PAR-1 or thrombin-induced cytokine production and adhesion factor expression of human umbilical vein endothelial cells was also seen to depend on SPHK1. Using dermal microvascular endothelial cells from SPHK1-deficient mice, we showed that absence of the enzyme abrogates MCP-1 production induced in these cells upon treatment with thrombin or PAR-1 activating peptide. We propose SPHK1 inhibition as a novel way to block PAR-1 mediated signalling, which could be useful in treatment of a number of diseases, in particular in atherosclerosis.
...
PMID:Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells. 1916 17
<< Previous
1
2
3
4
5
Next >>